SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

fertility

Fertility Blood Tests for Women: AMH, FSH, and More Explained

Fertility testing for women typically starts with AMH (anti-Müllerian hormone) to estimate ovarian reserve, FSH and estradiol on day 3 of the cycle, and a thyroid panel. Together these give a starting picture — though no single number predicts pregnancy on its own.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

What is ovarian reserve testing, and why does it matter?

Ovarian reserve refers to the quantity and quality of remaining eggs. Every person assigned female at birth is born with a finite number of eggs; this pool gradually declines throughout life and accelerates in the years before menopause. Ovarian reserve testing cannot predict whether you will conceive naturally, but it does help clinicians understand how you are likely to respond to fertility medications and how urgent further evaluation might be.

The American Society for Reproductive Medicine recommends that a fertility evaluation for women include assessment of ovarian reserve, uterine anatomy, and fallopian tube status, in addition to a partner semen analysis when applicable 1.

What does AMH measure, and how is it interpreted?

Anti-Müllerian hormone (AMH) is secreted by small follicles in the ovary and reflects the size of the remaining egg pool. It can be measured on any day of the menstrual cycle, making it practically convenient.

  • Higher AMH generally suggests more eggs remaining (a higher ovarian reserve)
  • Lower AMH suggests fewer eggs remaining (diminished ovarian reserve, or DOR)
  • Very high AMH may be seen in PCOS, where many follicles are present but ovulation is irregular

AMH results are interpreted alongside age, antral follicle count (a transvaginal ultrasound measurement), and clinical history. A single low AMH number does not mean you cannot conceive — it means you may respond less robustly to fertility medications and that time may be a more relevant factor.

What is a day 3 FSH and estradiol test?

Follicle-stimulating hormone (FSH) is measured on days 2, 3, or 4 of the menstrual cycle (day 1 is the first day of full flow). FSH stimulates follicle development; when the ovarian reserve is low, the pituitary gland compensates by producing more FSH. An elevated day 3 FSH therefore suggests diminished ovarian reserve.

Estradiol is measured at the same time because an elevated estradiol can suppress FSH, making the FSH appear falsely normal — a low FSH paired with a high estradiol may still indicate concerns about reserve.

The specific numeric thresholds for 'normal' vs. 'elevated' vary by laboratory. Your reproductive endocrinologist will interpret the result in the context of your lab's reference range, your age, and your AMH.

What other blood tests are part of a fertility workup?

A complete fertility evaluation typically includes 1:

Thyroid panel (TSH at minimum): Thyroid dysfunction — both underactive and overactive thyroid — can impair ovulation and increase miscarriage risk. TSH is a sensitive screen; if abnormal, free T4 and thyroid antibodies may follow.

Prolactin: Elevated prolactin (hyperprolactinemia) inhibits ovulation. It is often checked as part of a workup for irregular cycles.

Luteinizing hormone (LH): Often measured alongside FSH. An elevated LH-to-FSH ratio on day 3 can be one signal of PCOS, though PCOS diagnosis relies on multiple criteria 2.

Complete blood count (CBC) and iron studies: Anemia affects energy and can complicate early pregnancy. Iron deficiency is common.

Sexually transmitted infection testing: Chlamydia and gonorrhea can cause tubal scarring that blocks fertilization. Many clinics include this routinely.

Genetic carrier screening: Some centers offer this during a fertility workup to identify recessive conditions that could be passed to a child.

Are there tests beyond bloodwork?

Blood tests are one part of a fertility evaluation. Clinicians typically also order:

  • Transvaginal ultrasound to count antral follicles (another ovarian reserve measure) and evaluate uterine structure and ovarian appearance
  • Hysterosalpingography (HSG) or saline-infused sonography to check whether the fallopian tubes are open and the uterine cavity is normal
  • Semen analysis for a male partner — this is non-invasive, inexpensive, and identifies a significant contributor to fertility challenges in roughly half of couples 3

What do these results mean for next steps?

Test results guide the conversation, not the conclusion. Normal results do not guarantee easy conception; abnormal results do not mean conception is impossible. What they do is allow a reproductive endocrinologist to:

  • Estimate how you are likely to respond to ovulation-stimulating medications
  • Discuss the relative urgency of moving to treatment versus continuing to try naturally
  • Identify modifiable factors (thyroid disease, hyperprolactinemia) that are worth treating first
  • Personalize an IVF protocol if that becomes the path forward

Results that fall outside typical ranges are a starting point for a conversation with your reproductive specialist — they are not a final answer.

Common questions

Can I ask my primary care doctor or OB-GYN to order these tests?

Yes. AMH, FSH, estradiol, and a thyroid panel are standard lab tests that most clinicians can order. Interpretation in the context of fertility planning is best done by a reproductive endocrinologist, but having initial results before a specialist appointment can save time.

Can AMH be improved?

The egg pool itself does not increase with supplementation or lifestyle change. AMH levels may fluctuate slightly between tests and are affected by hormonal contraception (which can suppress AMH temporarily). Addressing overall health — nutrition, thyroid function, avoiding smoking — supports reproductive health generally but does not add eggs to the pool.

At what age should I consider baseline fertility testing?

There is no universal answer. Women who want children in their mid- to late-30s and are not yet trying may find value in baseline AMH testing as one data point in their planning. Women under 35 who have been trying to conceive for 12 months, or over 35 who have been trying for 6 months, are typically advised to seek evaluation.

What if all my tests are normal but I still cannot get pregnant?

Unexplained infertility is a recognized diagnosis — tests return normal for both partners but conception does not occur. It is common, accounting for a substantial proportion of infertility cases. Treatment options including IUI and IVF are effective in this situation even without a specific identified cause [4].

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

When to seek care

  • —Irregular or absent periods lasting more than a few months — warrants evaluation even before actively trying to conceive
  • —Symptoms of thyroid dysfunction: unexplained weight change, fatigue, hair thinning, temperature sensitivity
  • —History of pelvic inflammatory disease, chlamydia, gonorrhea, or prior pelvic surgery — increases tubal infertility risk and warrants earlier evaluation

This article is for general education. Blood test interpretation should be done by a clinician with knowledge of your full history. Fertility specialist care is provided by reproductive endocrinologists; Gale can help you prepare for those appointments.

References

  1. 1.Practice Committee of the American Society for Reproductive Medicine (2021). Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2021.08.038 ✓Scope of fertility evaluation including ovarian reserve testing, TSH, prolactin, HSG, and semen analysis
  2. 2.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. doi:10.1093/humrep/deh098 ✓PCOS diagnostic criteria involving LH/FSH ratio and the multi-criteria approach to diagnosis
  3. 3.Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, Mulhall JP, Niederberger C, Sandlow JI, Sokol RZ, Spandorfer SD, Tanrikut C, Treadwell JR, Oristaglio JT, Zini A (2021). Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I. Journal of Urology. doi:10.1097/JU.0000000000001521 ✓Semen analysis as a non-invasive, essential component of couples' infertility evaluation
  4. 4.Practice Committee of the American Society for Reproductive Medicine (2020). Evidence-based treatments for couples with unexplained infertility: a guideline. Fertility and Sterility. doi:10.1016/j.fertnstert.2019.10.014 ✓Treatment options for unexplained infertility including IUI and IVF with documented effectiveness

4 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.